Dr. Yanagihara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2317 Armstrong St
Honolulu, HI 96822Phone+1 408-425-3968
Summary
- Board certified medical oncologist specializing in lung and aerodigestive tract malignancies
Education & Training
- Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 1979 - 1982
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1977 - 1979
- University of HawaiiResidency, Internal Medicine, 1975 - 1977
- Cedars-Sinai Medical CenterInternship, Internal Medicine, 1974 - 1975
- University of Minnesota Medical SchoolClass of 1974
Certifications & Licensure
- HI State Medical License 1977 - 2026
- CA State Medical License 1982 - 2025
- TX State Medical License 1985 - 2016
- MD State Medical License 1979 - 1991
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 474 citationsLong-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a random...Lee S. Rosen, David Gordon, N. Simon Tchekmedyian, Ronald Yanagihara, Vera Hirsh
Cancer. 2004-06-15 - 516 citationsZoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial...Lee S. Rosen, David Gordon, Simon Tchekmedyian, Ronald Yanagihara, Vera Hirsh
Journal of Clinical Oncology. 2003-08-15 - 79 citationsMulticenter Phase II Trial of S-1 Plus Cisplatin in Patients With Untreated Advanced Gastric or Gastroesophageal Junction AdenocarcinomaJ. A. Ajani, F. C. Lee, D. A. Singh, D. G. Haller, Heinz-Josef Lenz
Journal of Clinical Oncology. 2006-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: